Results 51 to 60 of about 16,258 (219)
Avaliação do polimorfismo genético e atividade da enzina paroxonase em pacientes hipercolesterolêmicos [PDF]
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2004.A aterosclerose é a principal causa de morbidade e mortalidade no mundo ocidental e envolve ...
Favarin, Maria Elisa
core
Main Determinants of PON1 Activity in Hemodialysis Patients [PDF]
Cardiovascular diseases are the major cause of morbidity and mortality in hemodialysis (HD) patients. These patients present reduced paraoxonase 1 (PON1) activity that depends on genetic and non-genetic factors; however, how these factors influence PON1 ...
Costa, Elísio +13 more
core +1 more source
Paraoxonase-1 (PON1) gene polymorphisms have been closely associated with the development of advanced cancers while PON1 secretion to the serum is linked with inhibition of oxidized high-density lipoprotein by its antioxidative function.
M. B. Aldonza +7 more
semanticscholar +1 more source
The anti‐inflammatory effect of XuanBi Herbal Formula was evaluated in arthritic rat models, in which suppression of synovial inflammation was observed. The chemical ingredients of XuanBi were detected in both the decoction and rat peripheral blood. Potential targets of the formula were then intersected with previous synovial proteomic data, through ...
Hao Zhu +8 more
wiley +1 more source
Transduction of PEP-1-PON1 proteins into Raw 264.7 cells.
Cells were cultured in a 60-1-PON1 (0.1–0.3 µM) and control PON1 proteins were added to the culture media for 1 h (A), PEP-1-PON1 (0.3 µM) and control PON1 proteins were added to the culture media for 10–60 min (B), and analyzed by Western blot analysis.
Soo Young Choi (68011) +13 more
core +1 more source
Multi‐omics–driven precision medicine
Multi‐omics‐driven precision medicine (MODPM) provides a multiscale, continuously learnable framework that integrates genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiles, and clinical data. Powered by artificial intelligence and foundation models, MODPM enables cross‐modal representation learning, contextual modeling ...
Huibo Li +20 more
wiley +1 more source
Human Paraoxonase 1 as a Pharmacologic Agent: Limitations and Perspectives
Human PON1 (h-PON1) is a multifaceted enzyme and can hydrolyze (and inactivate) a wide range of substrates. The enzyme shows anti-inflammatory, antioxidative, antiatherogenic, ant-diabetic, antimicrobial, and organophosphate (OP)-detoxifying properties ...
Priyanka Bajaj +3 more
doaj +1 more source
PON1 is a multifunctional enzyme involved in oxidative stress and detoxification of some organophosphate (OP) pesticides. It has been associated with nervous system diseases like Alzheimer’s disease, amyotrophic lateral sclerosis, Parkinson’s disease ...
K. Huen +4 more
semanticscholar +1 more source
ABSTRACT While epidemiological studies link fine particulate matter (PM2.5) exposure to metabolic dysfunction‐associated steatotic liver disease (MASLD) and renal dysfunction, a translational gap exists, as most animal models utilize acute, high‐dose exposures that poorly reflect chronic, moderate‐level human scenarios.
Yi‐Siao Chen +11 more
wiley +1 more source
BackgroundParaoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein (HDL). PON1-activity, is heavily influenced by the PON1-Q192R polymorphism. PON1 is considered to protect against atherosclerosis, but it is unclear whether
Rakesh S Birjmohun +10 more
doaj +1 more source

